Mitsuyoshi Azuma
Direktor/Vorstandsmitglied bei Senju Pharmaceutical Co., Ltd.
Aktive Positionen von Mitsuyoshi Azuma
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Senju Pharmaceutical Co., Ltd.
 Senju Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Senju Pharmaceutical Co., Ltd. manufactures and distributes pharmaceuticals. It produces drugs for inflammation, allergy, glaucoma, cataract, and infection. The company was founded on April 9, 1947 and is headquartered in Osaka, Japan. | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | - | - | |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Mitsuyoshi Azuma
Ehemalige bekannte Positionen von Mitsuyoshi Azuma
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SemaThera, Inc.
 SemaThera, Inc. BiotechnologyHealth Technology SemaThera, Inc. engages in research and development in biotechnology. It develops novel inhibitors against semaphorin 3A (SEMA 3A) for prevention and reversal of diabetic macular edema (DME). The company is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Japan | 2 |
| Vereinigte Staaten | 2 |
| Kanada | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Senju Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Senju Pharmaceutical Co., Ltd. manufactures and distributes pharmaceuticals. It produces drugs for inflammation, allergy, glaucoma, cataract, and infection. The company was founded on April 9, 1947 and is headquartered in Osaka, Japan. | Health Technology |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
SemaThera, Inc.
SemaThera, Inc. BiotechnologyHealth Technology SemaThera, Inc. engages in research and development in biotechnology. It develops novel inhibitors against semaphorin 3A (SEMA 3A) for prevention and reversal of diabetic macular edema (DME). The company is headquartered in Montreal, Canada. | Health Technology |
- Börse
- Insiders
- Mitsuyoshi Azuma
- Erfahrung
